Anti-Insulin Receptor Antibody for Malignant Insulinoma and Refractory Hypoglycemia

N Engl J Med. 2023 Aug 24;389(8):767-769. doi: 10.1056/NEJMc2307576.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies / immunology
  • Humans
  • Hypoglycemia* / etiology
  • Hypoglycemia* / therapy
  • Insulin Antagonists* / immunology
  • Insulin Antagonists* / therapeutic use
  • Insulin* / immunology
  • Insulinoma* / complications
  • Insulinoma* / immunology
  • Insulinoma* / therapy
  • Pancreatic Neoplasms* / complications
  • Pancreatic Neoplasms* / immunology
  • Pancreatic Neoplasms* / therapy

Substances

  • Antibodies
  • Insulin
  • Insulin Antagonists